Skip to main content
Fig. 1 | Cancer & Metabolism

Fig. 1

From: Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling

Fig. 1

Multivariate analysis of plasma metabolites of patients with EMC (n = 142) and healthy controls (n = 154). A PCA separation of metabolomes of patients with EMC (blue) and healthy controls (green). B OPLS-DA separation of metabolomes of patients with EMC (blue) and healthy controls (green). C Multivariate analysis of plasma metabolites of patients with stage IA EMC (n = 85) and healthy controls (n = 154). PCA separation of metabolomes of patients with EMC (blue) and healthy controls (green). D OPLS-DA separation of metabolomes of patients with stage IA EMC (blue) and healthy controls (green). E Multivariate analysis of plasma metabolites of patients with stage IB-IV EMC (n = 57) and healthy controls (n = 154). PCA separation of metabolomes of patients with EMC (blue) and healthy controls (green). F OPLS-DA separation of metabolomes of patients with stage IB–IV EMC (blue) and healthy controls (green). Each point in the plot corresponds to one plasma sample

Back to article page

Cancer & Metabolism

ISSN: 2049-3002